Leukemia+Updated

Cellular Regulation and Leukemia

Overview of Cellular Regulation

  • Definition: Cellular regulation refers to the processes that control cell growth, division, and function, ensuring balance and response to internal and external stimuli.

  • Antecedents: Factors that can lead to alterations in cellular regulation include genetic mutations, environmental influences, and lifestyle choices.

  • Attributes: Key attributes of cellular regulation include homeostasis, genetic control, and the ability to adapt to changes.

Risk Factors for Alterations in Cellular Regulation

  • Modifiable Risk Factors:

    • Smoking

    • Exposure to carcinogens (chemicals, radiation)

    • Nutritional habits (malnutrition, obesity)

    • Alcohol consumption

    • Physical inactivity

  • Non-modifiable Risk Factors:

    • Age (increased risk with aging)

    • Genetic predisposition (family history of cancer)

    • Gender (specific cancers may have gender predisposition)

    • Ethnicity (highest incidence in certain populations)

Prevention and Screening Approaches

  • Regular screenings (e.g., mammograms, colonoscopies)

  • Lifestyle modifications (diet, exercise, avoiding smoking)

  • Vaccinations (e.g., HPV vaccine) to prevent related cancers

Clinical Manifestations and Pathophysiology of Leukemia

General Manifestations

  • Unexplained weight loss

  • Fatigue and decreased energy

  • Fever and night sweats

  • Frequent infections (due to immunosuppression)

  • Easy bruising or bleeding (related to platelet deficiency)

Pathophysiology

  • Overproduction of immature white blood cells (WBCs) in the bone marrow leads to:

    • Crowding out normal blood cell production, resulting in anemia (lack of red blood cells), thrombocytopenia (lack of platelets), and leukopenia (lack of functional WBCs).

  • Metastasis potential to liver, spleen, lymph nodes, and the central nervous system.

Types of Leukemia

  1. Acute Myeloid Leukemia (AML)

    • Most common type, mainly seen in older adults (median age ~68).

    • Characterized by rapid proliferation of myeloid blast cells leading to bone marrow failure.

    • Common Symptoms: Anemia, fatigue, bleeding, infections.

    • Risk Factors: Exposure to chemicals (e.g., benzene), previous chemotherapy, genetic disorders.

  2. Chronic Myeloid Leukemia (CML)

    • Slow-growing leukemia, averaging at 67 years of age at diagnosis.

    • Involves a chromosomal translocation leading to the Philadelphia chromosome.

    • Symptoms: Often asymptomatic but can present with B-symptoms like fever and fatigue.

    • Phases: Chronic phase, accelerated phase with symptoms, and blast phase with rapid progression.

    • Treatment: Chemo, HSCT, and targeted therapies like Tyrosine Kinase Inhibitors.

  3. Acute Lymphocytic Leukemia (ALL)

    • Most common in children (ages 2-10), peaks around age 4, and can occur in older adults.

    • Symptoms include fatigue, bleeding tendencies, and CNS involvement.

    • Treatment: Chemotherapy, CNS prophylaxis with intrathecal MTX, HSCT.

  4. Chronic Lymphocytic Leukemia (CLL)

    • Characterized by the accumulation of mature B-lymphocytes due to impaired apoptosis.

    • Average diagnosis at age 72; often asymptomatic and detected incidentally.

    • Symptoms: Enlarged lymph nodes, fatigue, occasional B-symptoms.

    • Treatment: Watchful waiting if asymptomatic, chemotherapy if symptoms develop, and regular cancer screenings due to increased risk of second malignancies.

Treatment Strategies for Leukemia

  • Chemotherapy: Induction, consolidation, and maintenance phases depending on leukemia type.

  • Hematopoietic Stem Cell Transplant (HSCT): More effective in younger patients with suitable donors.

  • Supportive Care: Managing symptoms, infections, and providing blood products.

  • Emerging Therapies: Targeted therapies have transformed prognosis for some leukemia types, particularly CML.